Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1 |
Northwestern University (Illinois) / Zibo Zhao, PhD |
Young Investigator Grants |
2018 |
Illinois |
Therapeutic Reactivation of p53 to Overcome Apoptotic Resistance in Pediatric Leukemia |
Dana-Farber Cancer Institute / Loren Walensky, MD, PhD & Kimberly Stegmaier, MD |
Reach Grants |
2015 |
Massachusetts |
Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma |
Duke University / Corinne Mary Linardic, MD, PhD |
Innovation Grants |
2013 |
North Carolina |
Theranostics in Children and Young Adults |
University of Iowa / Sue O'Dorisio, MD, PhD |
Springboard Grants |
2013 |
Iowa |
The YB1 Way of Surviving Radiation, Pediatric Brain Tumor Resistance and Recurrence |
Emory University / Abhinav Dey, PhD |
Young Investigator Grants |
2015 |
Georgia |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia |
Children's Hospital of Philadelphia / Wei Tong, PhD |
Innovation Grants |
2014 |
Pennsylvania |
The Therapy-Related Symptom Checklist for Children (TRSC-C): Systematic Monitoring of Symptoms to Improve Oncology Interventions.
|
Kansas Medical Center Research Institute, Inc. / Phoebe Williams |
Nurse Researcher Grants |
2008 |
Kansas |
The TC3 Line, a Zebrafish Model of T-Cell Malignancy
|
Huntsman Cancer Institute / Nathan Meeker, MD |
Young Investigator Grants |
2008 |
Utah |
The role of vitamin D in hepatoblastoma formation and prevention |
Brigham and Women's Hospital / Wolfram Goessling, MD/PhD |
Innovation Grants |
2012 |
Massachusetts |